A 22‐single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42
Open Access
- 15 June 2015
- journal article
- research article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 11 (12) , 1452-1460
Abstract
Introduction: The ability to identify individuals at increased genetic risk for Alzheimer's disease (AD) may streamline biomarker and drug trials and aid clinical and personal decision making.Methods: We evaluated the discriminative ability of a genetic risk score (GRS) covering 22 published genetic risk loci for AD in 1162 Flanders‐Belgian AD patients and 1019 controls and assessed correlations with family history, onset age, and cerebrospinal fluid (CSF) biomarkers (Aβ1–42, T‐Tau, P‐Tau181P).Results: A GRS including all single nucleotide polymorphisms (SNPs) and age‐specific APOE ε4 weights reached area under the curve (AUC) 0.70, which increased to AUC 0.78 for patients with familial predisposition. Risk of AD increased with GRS (odds ratio, 2.32 (95% confidence interval 2.08–2.58 per unit; P < 1.0e−15). Onset age and CSF Aβ1–42 decreased with increasing GRS (Ponset_age = 9.0e−11; PAβ = 8.9e−7).Discussion: The discriminative ability of this 22‐SNP GRS is still limited, but these data illustrate that incorporation of age‐specific weights improves discriminative ability. GRS‐phenotype correlations highlight the feasibility of identifying individuals at highest susceptibility.Keywords
Funding Information
- Alzheimer's Disease Research Foundation (SAO‐FRA S#13023)
- Departement Economie, Wetenschap en Innovatie
- Fonds Wetenschappelijk Onderzoek (FWO G026710N)
This publication has 26 references indexed in Scilit:
- Biomarker Modeling of Alzheimer’s DiseaseNeuron, 2013
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's diseaseNature Genetics, 2013
- TREM2 Variants in Alzheimer's DiseaseNew England Journal of Medicine, 2013
- Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s diseaseJournal of Neural Transmission, 2012
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's diseaseNature Genetics, 2011
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseNature Genetics, 2009
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's diseaseNature Genetics, 2009
- Forecasting the global burden of Alzheimer's diseaseAlzheimer's & Dementia, 2007